Free Trial

Lipocine (LPCN) Institutional Ownership

Lipocine logo
$3.62 -0.02 (-0.55%)
Closing price 04:00 PM Eastern
Extended Trading
$3.55 -0.07 (-1.96%)
As of 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)

Current
Institutional Ownership
Percentage
9.11%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$151.56K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$20.98K
Get LPCN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LPCN Institutional Buying and Selling by Quarter

Lipocine Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2025 Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673%
2/12/2025 Geode Capital Management LLC57,464$280K0.0%+6.0%1.074%
8/9/2024 Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480%
8/9/2024 Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222%
1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275%
10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353%
7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563%
6/5/2023 EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288%
5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855%
2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084%
2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332%
2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094%
11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106%
8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059%
7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084%
7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164%
5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743%
5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133%
4/26/2022 Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347%
2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499%
2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687%
11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357%
11/10/2021 Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355%
11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027%
10/19/2021 Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282%
8/16/2021 State Street Corp304,617$426K0.0%+2,356.6%0.345%
8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196%
8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071%
8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861%
8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321%
8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023%
8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125%
8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792%
8/10/2021 Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332%
8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023%
8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160%
5/19/2021 Virtu Financial LLC191,387$289K0.0%-8.0%0.217%
5/19/2021 Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095%
5/18/2021 Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063%
5/18/2021 Jane Street Group LLC29,060$44K0.0%N/A0.033%
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
5/17/2021 Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101%
5/17/2021 Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795%
5/14/2021 MML Investors Services LLC41,000$62K0.0%N/A0.046%
5/14/2021 XTX Topco Ltd29,929$45K0.0%N/A0.034%
5/13/2021 Barclays PLC21,594$33K0.0%N/A0.024%
5/12/2021 Northern Trust Corp148,222$224K0.0%+19.3%0.168%
5/12/2021 Geode Capital Management LLC603,713$911K0.0%+33.9%0.684%
5/11/2021 Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239%
5/10/2021 GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143%
(Data available from 1/1/2016 forward)

LPCN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LPCN shares?

During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on LPCN's institutional investors.

What percentage of Lipocine stock is owned by institutional investors?

9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings.

Which institutional investors have been buying Lipocine stock?

The following institutional investors have purchased Lipocine stock in the last 24 months: EP Wealth Advisors LLC ($66.98K), Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K).

How much institutional buying is happening at Lipocine?

Institutional investors have bought a total of 86,701 shares in the last 24 months. This purchase volume represents approximately $513.79K in transactions.

Which Lipocine major shareholders have been selling company stock?

The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($742.04K), and Renaissance Technologies LLC ($4.30K).

How much institutional selling is happening at Lipocine?

Institutional investors have sold a total of 746,335 shares in the last 24 months. This volume of shares sold represents approximately $3.73M in transactions.



This page (NASDAQ:LPCN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners